Previous 10 | Next 10 |
Company to host conference call and webcast on Tuesday, February 27, 2024, at 4:30 p.m. Eastern Time Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report fourth quarter and full year 2023 financial results on Tuesday, February 27, 2024, after the close of the U...
2024-02-08 13:15:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips With patience, some of the most undervalued biotech stocks can create massive wealth. Look at ACADIA Pharmaceuticals (NASDAQ: ACAD ), for example. At one point, it trade...
2024-02-07 04:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-01-30 16:58:14 ET More on Acadia Pharma Soleno Therapeutics And Acadia Pharmaceuticals: Hope For Prader-Willi Families Acadia Pharmaceuticals: Legal Overhang On Nuplazid Removed Acadia's Daybue: A Small Patient Pool Making Big Waves Needham upgrades Acad...
2024-01-24 17:40:22 ET More on Acadia Pharma Soleno Therapeutics And Acadia Pharmaceuticals: Hope For Prader-Willi Families Acadia Pharmaceuticals: Legal Overhang On Nuplazid Removed Acadia's Daybue: A Small Patient Pool Making Big Waves Bristol-Karuna deal: ...
2024-01-24 07:30:02 ET RBC Capital analyst issues MARKET OUTPERFORM recommendation for ACAD on January 24, 2024 07:00AM ET. The previous analyst recommendation was Market Outperform. ACAD was trading at $28.15 at issue of the analyst recommendation. The overall analyst c...
2024-01-22 22:42:14 ET Summary ACADIA Pharmaceuticals and Soleno Therapeutics are both conducting late-stage trials for the treatment of Prader-Willi Syndrome. PWS is a rare disease characterized by various physical and developmental challenges. Acadia is an established commer...
2024-01-22 11:29:07 ET More on S&P 500 Index: S&P 500 Sets New Record High As Investors Potentially Shift Focus To Q2 2024 Market Rally Met With Outflows S&P 500: The 'Pump' Is Underway - Watch Out For The 'Dump' S&P won't get the helping hand...
Acadia Pharmaceuticals Inc . (Nasdaq: ACAD) is saddened to announce the passing of its former President, Srdjan (Serge) Stankovic M.D., M.S.P.H. Serge passed away peacefully on December 29, 2023, following a prolonged illness. “Serge” as he was known to friends and colleagues,...
2024-01-03 07:00:00 ET Summary The biotech industry experienced a challenging year in 2023 due to a rising 10-year Treasury yield. In 2024, the 10-year yield should favorably support biotech stocks. Promising advancements in weight loss drugs, neuroscience, oncology, and gene ...
News, Short Squeeze, Breakout and More Instantly...
ACADIA Pharmaceuticals Inc. Company Name:
ACAD Stock Symbol:
NASDAQ Market:
ACADIA Pharmaceuticals Inc. Website:
U.S. drug wholesaler Cencora Inc (NYSE:COR), formerly AmerisourceBergen, is notifying affected individuals about their personal...
— Video series created by Rett caregiver and award-winning TV producer, AJ Tesler, and family, showcases the adapted adventures of families living with Rett syndrome — Documentary series to be showcased on Rett Revealed, a website designed to explain and highlight life with ...